Twenty-four-month interim results from a prospective, single-arm clinical trial evaluating the performance and safety of cellular bone allograft in patients undergoing lumbar spinal fusion.

导出 OA

翻译打印收藏纠错

第一作者： Daniel K,Park

第一单位： Beaumont Hospital, 3601 W 13 Mile Rd., Royal Oak, MI, USA. danparkmd@gmail.com.

作者： Daniel K,Park ^[1] ; Joshua J,Wind ^[2] ; Todd,Lansford ^[3] ; Pierce,Nunley ^[4] ; Timothy A,Peppers ^[5] ; Anthony,Russo ^[6] ; Hamid,Hassanzadeh ^[7] ; Jonathan,Sembrano ^[8] ; Jung,Yoo ^[9] ; Jonathan,Sales ^[10]

作者单位： Beaumont Hospital, 3601 W 13 Mile Rd., Royal Oak, MI, USA. danparkmd@gmail.com. ^[1] Sibley Memorial Hospital, 5255 Loughboro Rd. NW, Washington DC, USA. ^[2] South Carolina Sports Medicine, 9100 Medcom, N Charleston, SC, USA. ^[3] Spine Institute of Louisiana, 1500 Line Ave, Shreveport, LA, USA. ^[4] Scripps Memorial Hospital Encinitas, 354 Santa Fe Drive, Encinitas, CA, USA. ^[5] Yellowstone Orthopedic and Spine Institute, Billings Clinic Bozeman , 3905 Wellness Way, Bozeman, MT , MT, USA. ^[6] John Hopkins Medicine, 6420 Rockledge Dr, Bethesda, MD, USA. ^[7] University of Minnesota, 909 Fulton St SE, Minneapolis, MN, USA. ^[8] Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, USA. ^[9] Summit Spine, 9155 SW Barnes Rd. 210, Portland, OR, USA. ^[10]

关键词 Arthrodesis CBA Cellular allograft Lumbar fusion Trinity Elite